Asthma Inhaler Device Market

Company Headquarters: Parma, Italy Founded: 1935 Workforce: ~5624 Company Working: CHIESI Farmaceutici SpA (Chiesi) is an international research-focused Healthcare Group. Chiesi mainly focuses on the research, development, and marketing of the innovative drugs in respiratory therapeutics, specialty medicine, and rare disease areas. Chiesi group has more than 80 years of experience in the pharmaceutical industry. The company has its presence in 26 countries. The company has its research and development organization in Pharma. However, it is integrated with six other R&D groups in France, the US, the UK, Sweden, and Denmark.

Company Headquarters: Dhaka, Bangladesh Founded: 1980 Workforce: ~3,800+ Company Working: Beximco Pharmaceuticals Ltd (Beximco) is an emerging generic drug company. The company has manufacturing facilities accredited by the regulatory authorities of Australia, European Union, Canada, and Brazil, among others. Beximco is consistently building upon its portfolio and currently producing more than 500 products encompassing broad therapeutic categories, and the company has created strong differentiation by offering a range of high-tech, specialized products that are difficult to imitate. Beximco exports its medicines to more than 50 countries around the world.

Company Headquarters: Ingelheim am Rhein, Germany Founded: 1885 Workforce: ~50,370 Company Working: Boehringer Ingelheim International GmbH (Boehringer Ingelheim) has more than 100 years of legacy. Boehringer Ingelheim GmbH is a highly focused research-driven pharmaceutical company. The main focus of the company is to cure diseases with the help of its core R&D expertise. It constantly works to create solutions that go beyond treating the illness to have a positive impact on patients’ lives, on societies, and on science itself.

Company Headquarters: Mumbai, India Founded: 1935 Workforce: ~25,000+ Company Working: Cipla Inc. (Cipla) is a global pharmaceutical company with a portfolio of over 1000 products across a wide range of therapeutic categories with one quality standard globally. Its products are available in more than 50 dosage forms. The company has 46 manufacturing facilities for the production of APIs and formulations across various therapeutic categories. Its products are in compliance with the Medicines and Healthcare Products Regulatory Agency (MHRA), US FDA, Danish Medicines Agency, Health Canada, Federal Ministry of Health, the National Health Surveillance Agency (ANVISA) Brazil, Medicines Control Council (MCC) South Africa, the Colombia National Food and Drug Surveillance Institute (INVIMA), and Australian Government Department of Health. Cipla has presence in India, the US, Germany, Norway, Spain, the UK, Sri Lanka, South Africa, Australia, and Brazil, among other countries.

Company Headquarters: Cambridge, UK Founded: 1999 Workforce: 83,100 Company Working: AstraZeneca is a leading biopharmaceutical company. It focuses on developing and commercializing prescribed medicines. It has three main therapy areas, namely, cardiovascular, and metabolic disease (CVMD), oncology, and respiratory. It is also active in areas such as neuroscience autoimmunity and infection. It has more than 164 projects in its pipeline, nine new molecular entities in its late-stage pipeline, and one new molecular entity approval in the last quarter of 2019. Its product portfolio includes medications in the field of oncology, cardiovascular, renal & metabolism, and respiratory diseases, among others. Geographically the company operates in more than 100 countries by offering its healthcare products to millions of people across the globe.

Company Headquarters: Amsterdam, Netherlands Founded: 1891 Workforce: 77,000 (2018) Company Working: Koninklijke Philips NV (Philips) is a market leader in healthcare technology. The company has a strong sales and distribution network worldwide and operates in more than 100 countries. Philips offers products through segments, including medical devices, health systems, cardiology, health tech, oncology, respiratory, fertility, and pregnancy. The company deals in maternity care, child care, and oral healthcare products; male grooming and beauty products; food preparation and home care products; and sleep and respiratory care products. It delivers diagnostic X-ray, integrated clinical, magnetic resonance imaging, computed tomography, and molecular imaging solutions. Moreover, the company also offers healthcare information technology, clinical, and visualization and quantification informatics solutions for radiology, cardiology, and oncology; universal data management solutions, picture archiving and communication systems, and integrated electronic medical record systems; clinical and hospital IT platforms; technology-enabled monitoring and intervention, actionable program, cloud-based, and population health management software solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013.